AKTX
Akari Therapeutics, Plc
Price Chart
No historical data available
Latest Quote
$10.37
-0.06 (-0.58%)
Current Price
| Previous Close | $10.43 |
| Open | $10.44 |
| Day High | $10.50 |
| Day Low | $9.49 |
| Volume | 174,774 |
Stock Information
| Shares Outstanding | 1.95M |
| Total Debt | $693K |
| Cash Equivalents | $7.69M |
| Net Income | $-30.96M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $20.19M |
| Exchange | NCM |
Recent Price History
No history data available. Data will be fetched automatically.
About Akari Therapeutics, Plc
Akari Therapeutics, Plc, an oncology company, develops antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing. The company's lead product candidate is AKTX-101, a preclinical stage trop2-targeting ADC that combines PH1 with the trop2 antibody to treat solid tumor cancer types, including lung, breast, bladder, head and neck, gastric, pancreatic, colon, prostate, and others. Its payloads include PH1 is a novel payload that is a spliceosome modulator designed to disrupt RNA splicing within cancer cells. The company also develops AKTX-102, a novel bispecific ADC that utilizes PH1 as its payload to treat various solid tumor cancers. Akari Therapeutics, Plc is headquartered in Tampa, Florida.
đ° Latest News
No news articles available at the moment. Check back later for updates on AKTX.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $949,000 | $244,000 | $0 | - |
| Total Expenses | $12,095,000 | $16,647,000 | $16,806,000 | $23,088,000 |
| Other Income Expense | $-5,258,000 | $-2,908,000 | $6,716,000 | $5,294,000 |
| Other Non Operating Income Expenses | $2,984,000 | $-3,000 | $-19,000 | $-142,000 |
| Net Non Operating Interest Income Expense | $-948,000 | $-236,000 | $82,000 | $46,000 |
| Interest Expense Non Operating | $949,000 | $244,000 | $0 | - |
| Operating Expense | $12,095,000 | $16,647,000 | $16,806,000 | $23,088,000 |
| General And Administrative Expense | $9,280,000 | $9,664,000 | $11,356,000 | $13,527,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-17,298,000 | $-19,791,000 | $-10,008,000 | $-17,748,000 |
| Net Interest Income | $-948,000 | $-236,000 | $82,000 | $46,000 |
| Interest Income | $1,000 | $8,000 | $82,000 | $46,000 |
| Normalized Income | $-9,509,310 | $-16,886,000 | $-16,743,000 | $-23,184,000 |
| Net Income From Continuing And Discontinued Operation | $-17,298,000 | $-19,791,000 | $-10,008,000 | $-17,748,000 |
| Total Operating Income As Reported | $-17,275,000 | $-21,643,000 | $-16,806,000 | $-23,088,000 |
| Net Income Common Stockholders | $-17,298,000 | $-19,791,000 | $-10,008,000 | $-17,748,000 |
| Net Income | $-17,298,000 | $-19,791,000 | $-10,008,000 | $-17,748,000 |
| Net Income Including Noncontrolling Interests | $-17,298,000 | $-19,791,000 | $-10,008,000 | $-17,748,000 |
| Net Income Continuous Operations | $-17,298,000 | $-19,791,000 | $-10,008,000 | $-17,748,000 |
| Pretax Income | $-18,301,000 | $-19,791,000 | $-10,008,000 | $-17,748,000 |
| Special Income Charges | $-8,344,000 | $-4,996,000 | $0 | - |
| Interest Income Non Operating | $1,000 | $8,000 | $82,000 | $46,000 |
| Operating Income | $-12,095,000 | $-16,647,000 | $-16,806,000 | $-23,088,000 |
| Per Share | ||||
| Diluted EPS | $0.00 | $0.00 | $0.00 | $-216.00 |
| Basic EPS | $0.00 | $0.00 | $0.00 | $-216.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $-453,310 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-9,110,000 | $-16,628,000 | $-16,739,000 | $-28,520,000 |
| Total Unusual Items | $-8,242,000 | $-2,905,000 | $6,735,000 | $5,436,000 |
| Total Unusual Items Excluding Goodwill | $-8,242,000 | $-2,905,000 | $6,735,000 | $5,436,000 |
| Reconciled Depreciation | $0 | $14,000 | $4,000 | $4,000 |
| EBITDA (Bullshit earnings) | $-17,352,000 | $-19,533,000 | $-10,004,000 | $-23,084,000 |
| EBIT | $-17,352,000 | $-19,547,000 | $-10,008,000 | $-23,088,000 |
| Diluted Average Shares | $841,602 | $298,600 | $122,362 | $78,043 |
| Basic Average Shares | $841,602 | $298,600 | $122,362 | $78,043 |
| Diluted NI Availto Com Stockholders | $-17,298,000 | $-19,791,000 | $-10,008,000 | $-17,748,000 |
| Tax Provision | $-1,003,000 | $0 | - | - |
| Other Special Charges | $3,164,000 | - | - | - |
| Impairment Of Capital Assets | $5,180,000 | $0 | - | - |
| Restructuring And Mergern Acquisition | $0 | $4,996,000 | $0 | - |
| Gain On Sale Of Security | $102,000 | $2,091,000 | $6,735,000 | $5,436,000 |
| Research And Development | $2,815,000 | $6,983,000 | $5,450,000 | $9,561,000 |
| Selling General And Administration | $9,280,000 | $9,664,000 | $11,356,000 | $13,527,000 |
| Other Gand A | $9,280,000 | $9,664,000 | $11,356,000 | $13,527,000 |
Fetched: 2026-08-30
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-14,102,000 | $-25,381,000 | $-243,000 | $1,774,000 |
| Total Assets | $47,892,000 | $50,562,000 | $4,355,000 | $13,832,000 |
| Total Non Current Assets | $42,430,000 | $47,610,000 | $14,000 | $17,000 |
| Goodwill And Other Intangible Assets | $42,430,000 | $47,610,000 | $14,000 | $17,000 |
| Other Intangible Assets | $34,000,000 | $39,180,000 | $14,000 | $17,000 |
| Current Assets | $5,462,000 | $2,952,000 | $4,341,000 | $13,815,000 |
| Other Current Assets | $14,000 | $201,000 | $197,000 | $100,000 |
| Restricted Cash | $60,000 | $60,000 | $0 | - |
| Prepaid Assets | $185,000 | $92,000 | $299,000 | $465,000 |
| Cash Cash Equivalents And Short Term Investments | $5,203,000 | $2,599,000 | $3,845,000 | $13,250,000 |
| Cash And Cash Equivalents | $5,203,000 | $2,599,000 | $3,845,000 | $13,250,000 |
| Cash Financial | $5,203,000 | $2,599,000 | $3,845,000 | $13,250,000 |
| Debt | ||||
| Total Debt | $754,000 | $3,260,000 | - | - |
| Current Debt And Capital Lease Obligation | $754,000 | $3,260,000 | - | - |
| Current Debt | $754,000 | $3,260,000 | - | - |
| Other Current Borrowings | $673,000 | $950,000 | - | - |
| Net Debt | - | $661,000 | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $19,564,000 | $28,333,000 | $4,584,000 | $12,041,000 |
| Total Non Current Liabilities Net Minority Interest | $7,213,000 | $8,423,000 | $0 | $0 |
| Other Non Current Liabilities | $31,000 | $383,000 | - | - |
| Derivative Product Liabilities | $230,000 | $0 | - | - |
| Non Current Deferred Liabilities | $6,952,000 | $8,040,000 | $0 | - |
| Non Current Deferred Taxes Liabilities | $6,952,000 | $8,040,000 | $0 | - |
| Current Liabilities | $12,351,000 | $19,910,000 | $4,584,000 | $12,041,000 |
| Other Current Liabilities | $485,000 | $1,106,000 | $1,347,000 | $7,946,000 |
| Current Notes Payable | $81,000 | $2,310,000 | $0 | - |
| Payables And Accrued Expenses | $10,332,000 | $15,071,000 | $3,050,000 | $2,669,000 |
| Payables | $8,770,000 | $12,407,000 | $1,671,000 | $947,000 |
| Accounts Payable | $8,770,000 | $12,407,000 | $1,671,000 | $947,000 |
| Equity | ||||
| Common Stock Equity | $28,328,000 | $22,229,000 | $-229,000 | $1,791,000 |
| Total Equity Gross Minority Interest | $28,328,000 | $22,229,000 | $-229,000 | $1,791,000 |
| Stockholders Equity | $28,328,000 | $22,229,000 | $-229,000 | $1,791,000 |
| Gains Losses Not Affecting Retained Earnings | $-782,000 | $-738,000 | $-1,040,000 | $-771,000 |
| Other Equity Adjustments | $-782,000 | $-738,000 | $-1,040,000 | $-771,000 |
| Retained Earnings | $-264,550,000 | $-247,252,000 | $-227,461,000 | $-217,453,000 |
| Other | ||||
| Ordinary Shares Number | $90,536,879,533 | $53,186,919,523 | $13,234,315,298 | $7,444,917,123 |
| Share Issued | $90,536,879,533 | $53,186,919,523 | $13,234,315,298 | $7,444,917,123 |
| Tangible Book Value | $-14,102,000 | $-25,381,000 | $-243,000 | $1,774,000 |
| Invested Capital | $29,082,000 | $25,489,000 | $-229,000 | $1,791,000 |
| Working Capital | $-6,889,000 | $-16,958,000 | $-243,000 | $1,774,000 |
| Total Capitalization | $28,328,000 | $22,229,000 | $-229,000 | $1,791,000 |
| Additional Paid In Capital | $293,660,000 | $264,900,000 | $226,948,000 | $219,270,000 |
| Capital Stock | $0 | $5,319,000 | $1,324,000 | $745,000 |
| Common Stock | $0 | $5,319,000 | $1,324,000 | $745,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $780,000 | $473,000 | $187,000 | $1,426,000 |
| Current Accrued Expenses | $1,562,000 | $2,664,000 | $1,379,000 | $1,722,000 |
| Goodwill | $8,430,000 | $8,430,000 | - | - |
| Net PPE | - | - | - | - |
| Accumulated Depreciation | - | - | - | - |
| Gross PPE | - | - | - | - |
| Machinery Furniture Equipment | - | - | - | - |
Fetched: 2026-08-30
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-10,568,000 | $-12,552,000 | $-16,432,000 | $-21,504,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-10,568,000 | $-12,552,000 | $-16,432,000 | $-21,504,000 |
| Cash Flow From Continuing Operating Activities | $-10,568,000 | $-12,552,000 | $-16,432,000 | $-21,504,000 |
| Operating Gains Losses | $2,520,000 | $-1,830,000 | $-6,854,000 | $-5,317,000 |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $382,000 | $0 | - |
| Cash Flow From Continuing Investing Activities | $0 | $382,000 | $0 | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $10,725,000 | $11,815,000 | $7,016,000 | $25,194,000 |
| Financing Cash Flow | $13,171,000 | $10,988,000 | $7,020,000 | $25,288,000 |
| Cash Flow From Continuing Financing Activities | $13,171,000 | $10,988,000 | $7,020,000 | $25,288,000 |
| Net Common Stock Issuance | $10,725,000 | $11,815,000 | $7,016,000 | $25,194,000 |
| Common Stock Issuance | $10,725,000 | $11,815,000 | $7,016,000 | $25,194,000 |
| Net Other Financing Charges | - | $26,000 | - | - |
| Other | ||||
| Repayment Of Debt | $-1,052,000 | $-1,855,000 | $0 | - |
| Issuance Of Debt | $2,099,000 | $1,000,000 | $0 | - |
| Interest Paid Supplemental Data | $101,000 | $143,000 | $0 | - |
| Income Tax Paid Supplemental Data | $0 | $0 | - | - |
| End Cash Position | $5,263,000 | $2,659,000 | $3,845,000 | $13,250,000 |
| Beginning Cash Position | $2,659,000 | $3,845,000 | $13,250,000 | $9,361,000 |
| Effect Of Exchange Rate Changes | $1,000 | $-4,000 | $7,000 | $105,000 |
| Changes In Cash | $2,603,000 | $-1,182,000 | $-9,412,000 | $3,784,000 |
| Proceeds From Stock Option Exercised | $1,399,000 | $2,000 | $4,000 | $94,000 |
| Net Issuance Payments Of Debt | $1,047,000 | $-855,000 | $0 | - |
| Net Short Term Debt Issuance | $1,047,000 | $-855,000 | $0 | - |
| Short Term Debt Payments | $-1,052,000 | $-1,855,000 | $0 | - |
| Short Term Debt Issuance | $2,099,000 | $1,000,000 | $0 | - |
| Net Business Purchase And Sale | $0 | $382,000 | $0 | - |
| Sale Of Business | $0 | $382,000 | $0 | - |
| Change In Working Capital | $-404,000 | $6,539,000 | $-866,000 | $822,000 |
| Change In Payables And Accrued Expense | $-998,000 | $5,223,000 | $-936,000 | $-877,000 |
| Change In Prepaid Assets | $594,000 | $1,316,000 | $70,000 | $1,699,000 |
| Other Non Cash Items | $-2,368,000 | $271,000 | $142,000 | - |
| Stock Based Compensation | $2,890,000 | $2,245,000 | $1,150,000 | $735,000 |
| Asset Impairment Charge | $5,180,000 | $0 | - | - |
| Deferred Tax | $-1,088,000 | $0 | - | - |
| Deferred Income Tax | $-1,088,000 | $0 | - | - |
| Depreciation Amortization Depletion | $0 | $14,000 | $4,000 | $4,000 |
| Depreciation And Amortization | $0 | $14,000 | $4,000 | $4,000 |
| Gain Loss On Investment Securities | $-545,000 | $-2,085,000 | $-6,599,000 | $-4,983,000 |
| Net Foreign Currency Exchange Gain Loss | $-99,000 | $255,000 | $-255,000 | $-334,000 |
| Net Income From Continuing Operations | $-17,298,000 | $-19,791,000 | $-10,008,000 | $-17,748,000 |
Fetched: 2026-08-30